|
Feb 20
|
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
|
|
Feb 19
|
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
|
|
Feb 19
|
Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
|
|
Feb 19
|
Why Moderna (MRNA) Went Up on Tuesday?
|
|
Feb 19
|
Challenges mount for vaccine makers
|
|
Feb 18
|
Why Moderna (MRNA) Stock Is Up Today
|
|
Feb 18
|
Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook
|
|
Feb 18
|
Moderna has limited upside: Barclays
|
|
Feb 18
|
Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?
|
|
Feb 18
|
Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?
|
|
Feb 18
|
First Cows, Now Cats. Is Bird Flu Coming for Humans Next?
|
|
Feb 17
|
Moderna reports decline in Q4 2024 revenue
|
|
Feb 15
|
Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts
|
|
Feb 15
|
Q4 2024 Moderna Inc Earnings Call
|
|
Feb 14
|
These Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More
|
|
Feb 14
|
Moderna Stock Reverses As CEO Stephane Bancel Deflects Concerns Over RFK Jr.
|
|
Feb 14
|
Moderna Reports Another Quarterly Loss
|
|
Feb 14
|
Moderna (MRNA) Q4 2024 Earnings Call Transcript
|
|
Feb 14
|
Moderna’s Shot Sales, Canceled Contract Lead to Another Loss
|
|
Feb 14
|
Top Midday Stories: Meta Making Big Push Into AI-Powered Humanoid Robots; Moderna Shares Rise Despite Worse-Than-Expected Q4 EPS Loss
|